date,title,source
Oct-23-18,Enanta Pharmaceuticals Announces Positive Phase 1 Results and Initiation of Phase 2a Clinical Study of EDP-938 for Respiratory Syncytial Virus,Business Wire
Oct-26-18,"Report: Developing Opportunities within Assured Guaranty, Potbelly, Enanta Pharmaceuticals, Seagate Technology, Ctrip.com International, and CyberArk Software  Future Expectations, Projections Moving into 2018",GlobeNewswire
